These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 38612415)

  • 1. Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials.
    D'Angelo M; Steardo L
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use.
    Blebea NM; Pricopie AI; Vlad RA; Hancu G
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the role of cannabinoids on osteoporosis: a review.
    Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
    Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
    Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
    J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance.
    Narayan AJ; Downey LA; Manning B; Hayley AC
    Neurosci Biobehav Rev; 2022 Dec; 143():104941. PubMed ID: 36370842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
    Nahler G
    Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.
    Junior NCF; Dos-Santos-Pereira M; Guimarães FS; Del Bel E
    Neurotox Res; 2020 Jan; 37(1):12-29. PubMed ID: 31637586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies.
    Suraev AS; Marshall NS; Vandrey R; McCartney D; Benson MJ; McGregor IS; Grunstein RR; Hoyos CM
    Sleep Med Rev; 2020 Oct; 53():101339. PubMed ID: 32603954
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Canseco-Alba A; Rodríguez-Manzo G
    Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists.
    Monti JM; Pandi-Perumal SR
    Clin Neuropharmacol; 2022 Mar-Apr 01; 45(2):27-31. PubMed ID: 35221321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 13. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.
    Karimian Azari E; Kerrigan A; O'Connor A
    J Diet Suppl; 2020; 17(5):625-650. PubMed ID: 32677481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
    Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE; Friedman D
    Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anxiolytic effects of cannabinoids: A comprehensive review.
    Mallick K; Khan MF; Banerjee S
    Pharmacol Biochem Behav; 2024 Oct; 243():173828. PubMed ID: 39032530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
    Dos Santos RG; Hallak JEC; Crippa JAS
    Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.
    de Camargo RW; de Novais Júnior LR; da Silva LM; Meneguzzo V; Daros GC; da Silva MG; de Bitencourt RM
    Pharmacol Biochem Behav; 2022 Nov; 221():173492. PubMed ID: 36379443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Cannabidiol Safety: A Review.
    Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
    Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.